Financhill
Sell
39

EUDA Quote, Financials, Valuation and Earnings

Last price:
$4.31
Seasonality move :
16.61%
Day range:
$4.05 - $4.38
52-week range:
$1.20 - $6.30
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
61.25x
P/B ratio:
--
Volume:
100.4K
Avg. volume:
104.8K
1-year change:
187.84%
Market cap:
$158.3M
Revenue:
$3.7M
EPS (TTM):
-$0.64

Analysts' Opinion

  • Consensus Rating
    EUDA Health Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $6.00, EUDA Health Holdings has an estimated upside of 40.85% from its current price of $4.26.
  • Price Target Downside
    According to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $4.26.

Fair Value

  • According to the consensus of 1 analyst, EUDA Health Holdings has 40.85% upside to fair value with a price target of $6.00 per share.

EUDA vs. S&P 500

  • Over the past 5 trading days, EUDA Health Holdings has underperformed the S&P 500 by -3.93% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • EUDA Health Holdings does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • EUDA Health Holdings has grown year-over-year revenues for 0 quarters straight. In the most recent quarter EUDA Health Holdings reported revenues of --.

Earnings Growth

  • EUDA Health Holdings has grown year-over-year earnings for 0 quarters straight. In the most recent quarter EUDA Health Holdings reported earnings per share of --.
Enterprise value:
160.4M
EV / Invested capital:
--
Price / LTM sales:
61.25x
EV / EBIT:
29.39x
EV / Revenue:
122.57x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-123.43x
Price / Operating cash flow:
39.19x
Enterprise value / EBITDA:
25.77x
Gross Profit (TTM):
-$444.2K
Return On Assets:
-344.5%
Net Income Margin (TTM):
-1319.98%
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2021-06-30 2022-06-30 2023-06-30 2022-06-30 2023-06-30
Income Statement
Revenue -- $10.5M $7.9M $2.4M $104.3K
Gross Profit -- -- -- $660.6K $40.1K
Operating Income -- -- -- -$1.7M -$739K
EBITDA -- -- -- -$1.7M -$4.8M
Diluted EPS -- -- -- -$0.20 -$0.28
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Balance Sheet
Current Assets -- -- $4.2M $1.5M $1.1M
Total Assets -- -- $7.1M $2.1M $2M
Current Liabilities -- -- $8M $7.9M $7.9M
Total Liabilities -- -- $8.1M $8.1M $8M
Total Equity -- -- -$1M -$6M -$6M
Total Debt -- -- -- -- $2.5M
Trailing 12 Months Fiscal Quarters
Period Ending 2021-06-30 2022-06-30 2023-06-30 2022-06-30 2023-06-30
Cash Flow Statement
Cash Flow Operations -- -$1.3M -- -$976.7K -$1.7M
Cash From Investing -- -- -- -$124.1K -$1.1K
Cash From Financing -- -- -- $1M $1.2M
Free Cash Flow -- -- -- -- --
EUDA
Sector
Market Cap
$158.3M
$43.4M
Price % of 52-Week High
67.62%
48.26%
Dividend Yield
0%
0%
Shareholder Yield
-0.74%
-0.75%
1-Year Price Total Return
187.84%
-34.26%
Beta (5-Year)
--
0.749
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $4.14
200-day SMA
Buy
Level $3.80
Bollinger Bands (100)
Sell
Level 3.77 - 4.75
Chaikin Money Flow
Sell
Level -22.3M
20-day SMA
Buy
Level $3.88
Relative Strength Index (RSI14)
Buy
Level 54.06
ADX Line
Buy
Level 17.42
Williams %R
Neutral
Level -22.4299
50-day SMA
Sell
Level $4.33
MACD (12, 26)
Sell
Level -0.01
25-day Aroon Oscillator
Buy
Level 40
On Balance Volume
Neutral
Level 63.4M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-60.3853)
Sell
CA Score (Annual)
Level (-7.3464)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (54.7184)
Buy
Piotroski F Score (Annual)
Level (4)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company’s proprietary unified AI platform quickly assesses a patient’s medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.

Stock Forecast FAQ

In the current month, EUDA has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EUDA average analyst price target in the past 3 months is $6.00.

  • Where Will EUDA Health Holdings Stock Be In 1 Year?

    According to analysts, the consensus estimate is that EUDA Health Holdings share price will rise to $6.00 per share over the next 12 months.

  • What Do Analysts Say About EUDA Health Holdings?

    Analysts are divided on their view about EUDA Health Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that EUDA Health Holdings is a Sell and believe this share price will drop from its current level to $6.00.

  • What Is EUDA Health Holdings's Price Target?

    The price target for EUDA Health Holdings over the next 1-year time period is forecast to be $6.00 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is EUDA A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for EUDA Health Holdings is a Buy. 1 of 1 analysts rates the stock a Buy at this time.

  • How Can I Buy Shares Of EUDA?

    You can purchase shares of EUDA Health Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase EUDA Health Holdings shares.

  • What Is The EUDA Health Holdings Share Price Today?

    EUDA Health Holdings was last trading at $4.31 per share. This represents the most recent stock quote for EUDA Health Holdings. Yesterday, EUDA Health Holdings closed at $4.26 per share.

  • How To Buy EUDA Health Holdings Stock Online?

    In order to purchase EUDA Health Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Tesla Stock Falling?
Why Is Tesla Stock Falling?

Tesla stock reached an all-time high of $479.86 on December…

Is DoorDash a Buy, Sell or Hold?
Is DoorDash a Buy, Sell or Hold?

Gig economy food delivery service DoorDash (NASDAQ:DASH) has been running…

Is Clorox’s Dividend Worth It?
Is Clorox’s Dividend Worth It?

Clorox (NYSE:CLX) is the parent company of some of the…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 116x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $3T
P/E Ratio: 35x

Alerts

Buy
87
PCOR alert for Feb 15

Procore Technologies [PCOR] is up 16.3% over the past day.

Buy
54
DKNG alert for Feb 15

DraftKings [DKNG] is up 15.24% over the past day.

Sell
30
TWLO alert for Feb 15

Twilio [TWLO] is down 15.01% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock